|本期目录/Table of Contents|

[1]许红昕,李思瓯.血清C肽在糖尿病微血管并发症中作用的研究进展[J].慢性病学杂志,2020,21(10):1497-1500.
点击复制

血清C肽在糖尿病微血管并发症中作用的研究进展

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
21
期数:
2020年10期
页码:
1497-1500
栏目:
综 述
出版日期:
2020-09-28

文章信息/Info

Title:
-
作者:
许红昕; 李思瓯
牡丹江医学院附属红旗医院内分泌科，黑龙江 牡丹江 157000
Author(s):
-
关键词:
C肽; 糖尿病并发症; Na + -K + -ATP酶; 一氧化氮合酶; 活性氧
Keywords:
-
分类号:
R587.1
DOI:
-
摘要:
C肽是胰岛β细胞分泌的肽类。对糖尿病动物模型的研究和对1型糖尿病患者的早期临床试验表明，C肽的 细胞内效应可能有助于预防和改善糖尿病相关的肾脏、视网膜病变。关于C肽的作用机理尚有许多知识需要了 解，本文就C肽的作用机制及其在糖尿病视网膜病变、糖尿病肾病中的研究进展进行综述。
Abstract:
-

参考文献/References:

[1] Henriksson M, Nordling E, Melles E, et al. Separate functional features of proinsulin C- peptide [J]. Cell Mol Life Sci,2005,62(15):1772-1778. [2] Polonsky KS, Given BD, Van Cauter E. Twenty- four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects [J]. J Clin Invest, 1988,81(2): 442-448. [3] Faber OK, Hagen C, Binder C,et al. Kinetics of human connecting peptide in normal and diabetic subjects [J]. J Clin Invest,1978,62(1):197-203. [4] Panero F, Novelli G, Zucco C,et al. Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients [J]. Di-abetes Care, 2009,32(2):301-305. [5] Kuhadiya ND, Prohaska B, Ghanim H,et al. Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes [J]. Di-abetes Obes Metab, 2019,21(4):1054-1057. [6] Ohtomo Y, Aperia A, Sahlgren B,et al. C-peptide stim-ulates rat renal tubular Na + , K + -ATPase activity in syner-gism with neuropeptide Y [J]. Diabetologia, 1996,39(2): 199-205. [7] Yosten GL, Kolar GR, Redlinger LJ,et al. Evidence for an interaction between proinsulin C- peptide and GPR146 [J]. J Endocrinol, 2013,218(2):B1-B8. [8] Martin JH, Aitken RJ, Bromfield EG,et al. Investigation into the presence and functional significance of proinsulin C-peptide in the female germlinedagger [J]. Biol Reprod, 2019,100(5):1275-1289. [9] Johansson BL, Linde B, Wahren J. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utili-zation in the exercising forearm of type 1 (insulin-depen-dent) diabetic patients [J]. Diabetologia, 1992,35(12):1151-1158. [10] Wallerath T, Kunt T, Forst T,et al. Stimulation of en-dothelial nitric oxide synthase by proinsulin C-peptide [J]. Nitric Oxide,2003,9(2):95-102. [11] Yaribeygi H, Maleki M, Sathyapalan T,et al. The effect of C-peptide on diabetic nephropathy: A review of molecu-lar mechanisms [J]. Life Sci, 2019,237:116950. [12] Poteryaeva ON, Usynin IF. Molecular mechanisms of ac-tion and physiological effects of the proinsulin C- peptide (a systematic review) [J]. Biomed Khim, 2020,66(3):196-207. [13] Bhatt MP, Lim YC, Kim YM,et al. C-peptide activates AMPKalpha and prevents ROS-mediated mitochondrial fis-sion and endothelial apoptosis in diabetes [J]. Diabetes, 2013,62(11):3851-3862. [14] Essid SM, Bevington A, Brunskill NJ. Proinsulin C-Pep-tide Enhances Cell Survival and Protects against Simvas-tatin-Induced Myotoxicity in L6 Rat Myoblasts [J]. Int J Mol Sci,2019,20(7):1654. [15] Ahmed OM, Ali TM, Abdel GM,et al. Effects of enala-pril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-alpha, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats [J]. PLoS One, 2019,14(9): e214349. [16] Nordquist L, Brown R, Fasching A,et al. Proinsulin C-peptide reduces diabetes- induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodi-um reabsorption [J]. Am J Physiol Renal Physiol, 2009, 297(5):F1265-F1272. [17] Cai X, Han X, Zhang S,et al. Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese [J]. PLoS One,2014,9(3):e91174. [18] Mosier MA. Circulating C-peptide and diabetic retinopathy [J]. Diabetes Res, 1984,1(3):151-154. [19] Ido Y, Vindigni A, Chang K, et al. Prevention of vascu-lar and neural dysfunction in diabetic rats by C- peptide [J]. Science, 1997,277(5325):563-566. [20] Lim YC, Bhatt MP, Kwon MH, et al. Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice [J]. Cardiovasc Res, 2014,101(1):155-164. [21] Williams KV, Becker DJ, Orchard TJ,et al. Persistent C-peptide levels and microvascular complications in child-hood onset type 1 diabetes of long duration [J]. J Diabetes Complications,2019,33(9):657-661.

备注/Memo

备注/Memo:
作者简介：许红昕，硕士研究生，住院医师，研究方向：血 清C肽与糖尿病微血管并发症相关性临床研究 通信作者：许红昕，E-mail:1016040140@qq.com
更新日期/Last Update: 2020-09-28